Mr. Tony O'Brien:

Roughly, yes. There is a way to go, but it is important to stress progress has been made. Also we are seeing changes, as I said, in prescriber behaviour, which will affect the overall number of prescriptions issued and the move towards always using the preferred drug, which will be the lowest priced clinically effective alternative.